Caribou Biosciences Inc (CRBU)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.570.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CRBU
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 10.0 | 11.2 | 10.0 | 34.5 | 13.9 | 9.6 | 12.4 |
| Operating Expenses & Income | |||||||
| R&D Expenses | 85.8 | 109.4 | 130.2 | 112.1 | 82.2 | 52.3 | 34.4 |
| Operating Income | (109.5) | (148.3) | (166.6) | (116.1) | (106.4) | (67.0) | (36.1) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | — | — | 0.0 | 0.0 |
| Other Non-Operating Income / Expenses | 5.5 | (0.3) | 17.5 | 14.2 | 7.0 | 0.4 | (0.0) |
| Asset Writedown | — | 12.2 | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (148.7) | (149.1) | (101.9) | (99.4) | (66.6) | (36.1) |
| Income Tax Expense | — | (0.6) | (0.0) | 0.2 | 0.1 | 0.3 | (1.8) |
| Net Income | |||||||
| Net Income | (103.4) | (148.1) | (149.1) | (102.1) | (99.4) | (66.9) | (34.3) |
| Per Share | |||||||
| Basic EPS | (1.02) | (1.59) | (1.65) | (1.38) | (1.64) | (2.11) | — |
| Diluted EPS | (1.02) | (1.59) | (1.65) | (1.38) | (1.64) | (2.11) | — |
| Revenue per Share | 0.10 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 101.0 | 93.4 | 90.3 | 73.8 | 60.8 | 31.7 | — |
| Diluted Weighted Avg Shares | 101.0 | 93.4 | 90.3 | 73.8 | 60.8 | 31.7 | — |
| Supplemental | |||||||
| EBITDA | — | (144.7) | (162.7) | (112.5) | (104.8) | (66.0) | (35.2) |
| EBIT | (109.5) | (148.3) | (166.6) | (116.1) | (106.4) | (67.0) | (36.1) |
| Effective Tax Rate | — | — | — | -0.2% | -0.1% | -0.5% | 5.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.